Replies to post #402408 on Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"Didn’t IpIx already sell/lose the rights to kevetrin?"
Neither, but with the same effect.....

From the last 10-K:
"At any time, we may decide to discontinue the development of, or to not commercialize, a drug candidate, such as our decision in December 2018 to discontinue the Prurisol psoriasis program, and our decision in September 2022 to discontinue the Kevetrin oncology program."